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Notch refers to a highly conserved cell-to-cell
signaling pathway with essential roles in embryonic
development and tissue maintenance. Dysfunctional
signaling causes human disease, highlighting the
importance of pathway regulation. Notch signaling
ultimately results in the activation of target genes,
which is regulated by the nuclear effector CSL
(CBF-1/RBP-J, Su(H), Lag-1). CSL dually functions
as an activator and a repressor of transcription
through differential interactions with coactivator
or corepressor proteins, respectively. Although the
structures of CSL-coactivator complexes have
been determined, the structures of CSL-corepressor
complexes are unknown. Here, using a combination
of structural, biophysical, and cellular approaches,
we characterize the structure and function of CSL
in complex with the corepressor KyoT2. Collectively,
our studies provide molecular insights into how
KyoT2 binds CSL with high affinity and competes
with coactivators, such as Notch, for binding CSL.
These studies are important for understanding how
CSL functions as both an activator and a repressor
of transcription of Notch target genes.
INTRODUCTION
The Notch pathway is an intercellular signaling mechanism
conserved inmetazoans (Kopan and Ilagan, 2009). Genetic abla-
tion of Notch signaling results in embryonic lethality (Swiatek
et al., 1994), whereas tissue-specific ablation results in severe
phenotypes and cellular dysfunction (Radtke et al., 1999),
emphasizing the essential role Notch plays during prenatal
development and themaintenance of adult tissues. Congruently,
mutations in pathway components underlie the pathogenesis of
many human diseases, including certain types of cancer and
congenital defects (Gridley, 2003; Koch and Radtke, 2010).
Given its prevalence with human disease, extensive efforts
have been directed toward developing reagents that modulate
Notch signaling for therapeutic purposes (Aster and Blacklow,
2012).
The central components consist of the receptor Notch,
the ligand DSL (Delta, Serrate, Lag-2), and the DNA binding70 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rightstranscription factor CSL (CBF-1/RBP-J, Su(H), Lag-1; Kovall
and Blacklow, 2010). Notch-DSL complexation initiates sig-
naling, which triggers proteolytic cleavage of Notch, thereby
leading to release of its intracellular domain, termed Notch
intracellular domain (NICD), from the cell membrane (Kopan
and Ilagan, 2009). Subsequently, NICD translocates to the
nucleus, where it binds CSL and the transcriptional coactivator
Mastermind (MAM). CSL, NICD, and MAM form a transcription-
ally active ternary complex that binds at promoter and enhancer
regions of Notch target genes, upregulating transcription at
these sites (Figure 1A).
CSL functions as a transcriptional repressor at some, but not
all, Notch target genes by interacting with corepressor proteins,
such as KyoT2, MINT/SHARP, and Hairless (Borggrefe and
Oswald, 2009). Corepressors are components of large multi-
protein, histone-modifying complexes, which link CSL to the
transcriptional repression machinery in the nucleus. An early
model in the field posited that CSL was constitutively bound to
DNA, and, upon pathway activation, NICD displaces corepres-
sors from CSL (Figure 1A; Hsieh and Hayward, 1995). However,
more recent studies have shown that CSL binding to DNA is a
much more dynamic process in vivo, whereby its occupancy
at target genes is increased when Notch is active (Krejcı´ and
Bray, 2007). Whether NICD exclusively competes with corepres-
sors for CSL binding or whether entire transcription complexes
are exchanged and/or turned over at Notch target genes
remains to be determined.
Our group and others have solved high-resolution X-ray struc-
tures of active Notch transcription complexes and assembly
intermediates including CSL, CSL-RBP-J-associated molecule
(CSL-RAM), and CSL-NICD-MAM ternary complexes bound to
DNA (Kovall and Blacklow, 2010). As shown in Figures 1B and
1C, the structural core of CSL is composed of three domains:
the NTD, the BTD, and the CTD. DNA binding and specificity is
mediated by the NTD and BTD. The RAM and ANK domains of
NICD interact with the BTD and CTD of CSL, respectively.
MAM, which binds an interface formed by CTD-ANK and the
NTD, locks the complex into an active conformation (Choi
et al., 2012). Subsequent biochemical and biophysical studies
have led to considerable insights into the assembly of the
CSL-NICD-MAM ternary complex (Kovall and Blacklow, 2010);
however, the structures of CSL-corepressor complexes are
unknown, and the molecular differences between corepressor
and coactivator binding to CSL are poorly understood.
The corepressor KyoT2was originally identified in a yeast two-
hybrid screen for CSL binding partners (Taniguchi et al., 1998).
KyoT2, along with KyoT1 and KyoT3, are splice variants of thereserved
Figure 1. CSL-Mediated Transcriptional
Regulation
(A) In the absence of a Notch signal, CSL keeps
target genes in a repressed state through in-
teractions with transcriptional corepressors (left).
In the presence of a Notch signal, NICD trans-
locates to the nucleus and interacts with CSL and
the coactivator MAM, displacing corepressors
from CSL and resulting in the activation of
Notch target genes.
(B) The X-ray structure of CSL in complex with
NICD and MAM (Protein Data Bank [PDB] ID
code 2FO1), referred to as the ternary complex
(Wilson and Kovall, 2006). CSL is composed of the
N-terminal domain (NTD; cyan), the b-trefoil
domain (BTD; green), and the C-terminal domain
(CTD; orange). The RAM and ankyrin repeats
(ANK; yellow) domains of NICD bind the BTD
and CTD of CSL, respectively; MAM (gray) forms
a long a-helix, which binds along a groove formed
by ANK, CTD, and NTD.
(C) Domain schematic of core CSL (top), NICD
(middle), and MAM (bottom); domains are colored
as described in (B).
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Structure-Function of the CSL-KyoT2 ComplexKyoT gene (also known as Fhl1). KyoT1 and KyoT2 transcripts
are found in a wide range of tissues, with particularly high levels
in the skeletal muscle, heart, lung, and kidney (Taniguchi et al.,
1998). KyoT3 is also expressed in a variety of tissues, with higher
levels found in the brain, kidney, and pancreas (Liang et al.,
2008). All KyoT gene products encode proteins that have multi-
ple N-terminal LIM domains (Lin11, Isl-1, and Mec-3; Figure 2A)
and, due to differential splicing, KyoT2 and KyoT3, but not
KyoT1, contain a C-terminal region that binds CSL (CSL-ID; Fig-
ure 2A). Previous studies showed that KyoT2 and KyoT3 function
as potent repressors of Notch-mediated transcription in cells
and, consistent with this role, the LIM domains have been shown
to interact with Ring1 and HPC2—members of the Polycomb
group proteins involved in epigenetic silencing (Qin et al.,
2004, 2005). As shown in Figures 2B and 2C, the CSL-ID of
KyoT2 possesses a conserved hydrophobic tetrapeptide motif
(4W4P, where 4 is any hydrophobic residue) that is present in
the RAM domain of Notch and the viral transactivator EBNA2
(Ling and Hayward, 1995; Tamura et al., 1995). Whereas the
4W4P motif is essential for RAM and EBNA2 binding to the
BTD of CSL, Johnson et al. (2010) identified additional
conserved motifs in RAM that contribute to its high-affinity
interaction with BTD; these include an N-terminal basic region
and -HG- and -GF- dipeptide motifs (Figure 2C). Consistent
with these motifs contributing to high-affinity binding, EBNA2,
which does not contain these additional motifs, binds CSL with
50-fold less affinity (Johnson et al., 2010). Similar to EBNA2,
KyoT2 also does not contain these additional motifs found in
RAM (Figure 2C).
The overall goals of this study are to understand at the
structural level the complex formed between the corepressor
KyoT2 and CSL, the molecular differences between KyoT2
and RAM binding to CSL, and how the CSL-KyoT2 complex
functions to repress transcription of Notch target genes.
Here, we used X-ray crystallography and isothermal titration
calorimetry (ITC) to elucidate the structure and define theStructure 22binding affinity, respectively, of the CSL-KyoT2 complex. We
also analyzed mutants of both CSL and KyoT2, which revealed
differences in the binding interactions between KyoT2 and
RAM for CSL. Additionally, we used transcriptional reporter
assays in cells to functionally validate our structural and
binding studies. Taken together, our results provide important
insights into the structure and function of a CSL-corepressor
complex, which is critical for understanding how CSL functions
as both a repressor and an activator of transcription from Notch
target genes.
RESULTS
Structure of the CSL-KyoT2-DNA Complex
In order to determine the high-resolution structure of the CSL-
KyoT2 corepressor complex, we purified recombinant proteins
from bacteria corresponding to mouse CSL (residues 53–474)
andmouse KyoT2 (residues 184–210). As identified by Taniguchi
et al. (1998), the 27 C-terminal residues of KyoT2 (184–210)
correspond to the region of KyoT2 that is necessary to bind
CSL. CSL-KyoT2 complexes were mixed in equal molar ratios
with an oligomeric 15-mer DNA duplex containing a single CSL
binding site and screened for crystals. Initial screens of the
CSL-KyoT2 complex yielded no crystals; therefore, we designed
and purified a surface entropy reduction mutant of CSL (R115T),
which produced CSL-KyoT2-DNA crystals amenable to X-ray
diffraction analysis. An orthorhombic crystal form (P21) of
the CSL-KyoT2-DNA complex was obtained that diffracted to
2.85 A˚. The structure was solved by molecular replacement,
using previously determined CSL-DNA structures (Friedmann
and Kovall, 2010; Friedmann et al., 2008), revealing that two
CSL-KyoT2-DNA complexes were contained within the asym-
metric unit. The final model, which consists of residues 53–472
of CSL, residues 184–196 of KyoT2, and the 15-mer oligomeric
DNA duplex, was refined to 2.85 A˚ with an R factor and a free
R factor of 18.9% and 23.2%, respectively. The data collection,, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 71
Figure 2. KyoT2 Domain Schematics and
Sequence Comparison
(A) The KyoT gene gives rise to three different
isoforms: KyoT1, KyoT2, and KyoT3. KyoT1,
KyoT2, and KyoT3 contain four, two, and three LIM
domains, respectively. KyoT2 andKyoT3 contain a
CSL-interaction domain (CSL-ID).
(B) KyoT2 constructs used in this study.
(C) Sequence alignment of the RAM domains from
murine Notch1-4, Drosophila Notch (dNotch),
Epstein-Barr virus nuclear antigen 2 (EBNA2), the
worm Notch receptor LIN-12, and the CSL-ID of
KyoT2. The basic region, -HG- motif, 4W4Pmotif,
and -GF- motif are boxed and colored blue,
orange, green, and magenta, respectively. See
also Figure S1 for circular dichroism (CD) spec-
trum of KyoT2 (184–210).
Structure
Structure-Function of the CSL-KyoT2 Complexstructure determination, and refinement statistics are summa-
rized in Experimental Procedures and Table 1.
As shown in Figure 3, KyoT2 binds exclusively to the BTD of
CSL in an extended conformation, wherein its N-terminal resi-
dues (184–187) form a b strand with a large b-hairpin loop in
the BTD of CSL and its 4W4P motif (-VWWP-; residues 190–
193) binds a prominent nonpolar pocket on the surface of the
BTD. In isolation, residues 184–210 of KyoT2 have a circular
dichroism spectrum that is consistent with this region being
intrinsically disordered (Figure S1 available online). Electron
density for KyoT2 was only observed for residues 184–196,
suggesting that residues 197–210 are not required for binding
CSL, which was confirmed by our ITC binding studies of CSL-
KyoT2 complexes detailed below.
Overall, the two CSL-KyoT2-DNA complexes contained within
the asymmetric unit are very similar (Figure S2). The ca atoms
of the two CSL molecules align with a 0.66 root-mean-square
deviation (RMSD), and alignment of individual domains displays
greater correspondence with RMSDs of 0.27, 0.23, and 0.31 (ca
atoms) when the NTD, BTD, and CTD domains, respectively, are
overlayed. Despite very different crystal packing environments,
the conformations of the two KyoT2 molecules are also very
similar (0.24 RMSD for ca atoms; Figure S2E) and bury similar
amounts of surface area at the BTD-KyoT2 interface (874 A˚
and 928 A˚). The largest structural differences between the two
complexes occur within the CTD of CSL, i.e., remote from where
KyoT2 binds CSL. These include two b-hairpin loops in the CTD,
which assume different conformations, likely due to different
crystal packing interactions (Figures S2A and S2D). In addition,
the two CTD domains assume different degrees of rotation
relative to the NTD-BTD domains, resulting in differences of up
to 3 A˚ between corresponding ca atoms. Due to the lower
overall temperature factors at the BTD-KyoT2 interface, chains72 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reservedC (CSL) and D (KyoT2) were used for all
subsequent structural comparisons.
Given that both the RAM domain of
Notch and KyoT2 exclusively bind the
BTD, we next compared in detail the
interactions of these ligands with CSL.
Previously, four X-ray structures have
been determined that contain the CSL-RAM interaction: one structure of the CSL-NICD-MAM ternary
complex and two CSL-RAM structures for protein components
from C. elegans, and one structure of the human CSL-NICD-
MAM ternary complex that contains RAM (Choi et al., 2012;
Friedmann et al., 2008; Kovall and Hendrickson, 2004; Wilson
and Kovall, 2006). As shown in Figure 3C, when KyoT2 and
the RAM domains are overlayed, there is an overall structural
correspondence for how KyoT2 and RAM bind the BTD of
CSL. In particular, residues proximal to the 4W4P motif share
the largest degree of structural similarity; however, the structural
correspondence breaks down for N- and C-terminal residues
distal from the 4W4P motif. In particular, the basic region of
RAM, as well as the -HG- and -GF- motifs (Figure 2), shares little
to no structural similarity with KyoT2 (Figure 3C). It should also be
mentioned that the C-terminal residues of the human Notch1
RAM structure adopt a strikingly different conformation than
KyoT2 and the worm RAM structures. The authors of this study
speculated that the tandem proline residues following the
4W4P for worm RAM resulted in its elongated conformation,
whereas human Notch1 RAM does not contain this motif and
therefore adopts a striking bend at this position (Choi et al.,
2012). However, KyoT2 also does not contain this di-proline
motif, yet it adopts a conformation more similar to the worm
RAM structures. The functional significance in these two dif-
ferent binding modes remains to be determined. Nonetheless,
all CSL-RAM complex structures bury a similar amount of sur-
face area as does the CSL-KyoT2 binding interaction (Table S1).
Thermodynamic Analysis of CSL-KyoT2 Binding
Interactions
In order to characterize the binding interactions of CSL-KyoT2
complexes, we used ITC with our purified preparations of
CSL and KyoT2. As shown in Figure 4A and Table 2, KyoT2
Table 1. Data Collection and Refinement Statistics
Data Collection Statistics
Beam line APS LS-CAT 21-ID-F
Resolution (A˚) 40.3–2.85 (2.95–2.85)
Space group P21
Wavelength (A˚) 0.97872
Unit cell a, b, c (A˚) 62.16, 97.29, 144.10
Unit cell a, b, g () 90.00, 93.17, 90.00
Rmerge 0.053 (0.46)
I/sI 28.1 (2.2)
Completeness (%) 93.96 (66.6)
Redundancy 5.6 (3.2)
Average mosaicity () 0.19–0.28
Refinement Statistics
Rwork/Rfree (%) 18.8/23.1
Number of reflections 37,773
Number of atoms 8,168
Complexes/asymmetric unit 2
Wilson B/mean B value (A˚2) 105.45/108.71
RMSD bond lengths (A˚) 0.01
RMSD bond angles () 1.29
Ramachandran
(favored/outliers; %)
94.67/0.23
Highest resolution shell shown in parentheses.
Structure
Structure-Function of the CSL-KyoT2 Complex(184–210) forms a high-affinity 1:1 interaction with CSL that is
defined by an 12 nM KD, which is similar in magnitude to previ-
ous thermodynamic studies of CSL-RAMcomplexes (Friedmann
et al., 2008; Johnson et al., 2010). Consistent with KyoT2 being
intrinsically disordered prior to interactions with CSL, KyoT2
binding is enthalpically driven and entropically unfavorable.
The overall affinity of CSL for KyoT2 is unchanged when CSL is
bound to DNA (Figure 4B; Table 2); however, the enthalpic/
entropic contributions to binding are affected by as much as
4 kcal/mol. Given that both KyoT2 and DNA bind the BTD of
CSL, these data suggest that DNA binding to the BTD results
in structural ordering of the BTD, which diminishes the entropic
penalty for KyoT2-BTD complexation. Previously, we observed
similar enthalpic/entropic compensation for RAM binding to
CSL in the presence and absence of DNA (Friedmann et al.,
2008). Consistent with our CSL-KyoT2 structure, the affinity of
KyoT2 for the isolated BTD is comparable (i.e., within experi-
mental error) to its binding interactions with the structural core
of CSL (Figure 4C; Table 2).
In order to glean additional thermodynamic insights into CSL-
KyoT2 complexes, we determined the DCp associated with
KyoT2 binding to CSL. A negative DCp of binding is consistent
with burial of nonpolar surface area upon complexation and/or
folding coupled to binding (Sturtevant, 1977). As shown in
Figure 4F and Table 3, we analyzed the thermodynamic
parameters of binding (DH, TDS, and DG) as a function of
temperature. This analysis shows that the overall free energy
of binding for CSL-KyoT2 complexes is independent of
temperature and that the DCp of binding is 0.57 kcal/mol,K.
Previously, we found the DCp of binding for CSL-RAM com-Structure 22plexes to be0.62 kcal/mol,K (VanderWielen et al., 2011), which
is very similar to the value determined here for CSL-KyoT2
interactions.
Next, we sought to delineate the region in KyoT2 that main-
tains full affinity with CSL. Two C-terminal truncations in
KyoT2 (184–200 and 182–196) resulted in overall binding to
CSL similar to the KyoT2 construct 184–210 (Table 2; Figure 4E).
Similarly, N-terminally extended KyoT2 constructs (182–210
and 182–196) displayed no additional enhancements in
binding affinity compared with the 184–210 KyoT2 construct
(Figures 4D and 4E; Table 2). These data suggest that KyoT2
residues 184–196 are necessary and sufficient for binding
CSL, which is entirely consistent with our CSL-KyoT2 structure.
Subsequently, we pursued ITC binding studies to identify the
shortest peptide sequence in KyoT2 that still retains mea-
sureable and specific binding to CSL. To address this question,
we analyzed the binding of six additional KyoT2 peptides
of decreasing lengths. Remarkably, the tetrapeptide -VWWP-
of KyoT2 binds CSL with 8 mM affinity, which we confirmed
was specific by showing that the interaction was abrogated
with the BTD mutant F261R. It should also be mentioned
that there is a significant enhancement in binding (40-fold)
when the peptide -APVWWPMK- is lengthened by two residues
to -KAPVWWPMKD- (Table S2; Figure S3).
Although KyoT2 and RAM have strikingly similar overall
affinities for CSL, KyoT2 lacks the additional motifs identified
in RAM that contribute to its high-affinity binding (Johnson
et al., 2010). This suggests that KyoT2 and RAM utilize different
molecular interactions to achieve high-affinity binding with
CSL. In order to characterize these differences, we designed
mutations in CSL, KyoT2, and RAM and analyzed their binding
using ITC. Previously, we analyzed mutations in CSL that
targeted the interfaces of the CSL-NICD-MAM coactivator
complex (Yuan et al., 2012). Four mutations were targeted to
the BTD of CSL (Figure 3D), all of which showed substantially
reduced affinity for the RAM domains of Notch1 and Notch2
(Yuan et al., 2012). To determine whether these CSL mutants
also affected KyoT2 binding, we measured the binding of
KyoT2 with the BTD mutants F261R, V263R, A284R, and
Q333R. As shown in Figures 5C and 5E and Table 4, the CSL
mutants F261R and A284R have at least 500-fold reduced
binding to KyoT2, which is similar to what was observed for
thesemutants interacting with RAM (Yuan et al., 2012). However,
the BTD mutants V263R and Q333R had relatively modest
effects on KyoT2 binding (Figures 5D and 5F; Table 4), which is
significantly different than the 20-fold reduction in affinity
observed for these mutants binding to RAM. Interestingly, the
CSL mutants F261R and A284R lie at the interface with the
4W4P motifs of KyoT2 and RAM (Figure 3D), whereas the CSL
mutants V263R and Q333R target binding interactions outside
of the 4W4P motif, which is where KyoT2 and RAM binding
interactions with CSL diverge.
Next, we analyzed mutations in KyoT2 that target motifs
within and outside of the 4W4P. As expected, mutation of
the di-tryptophan motif within KyoT2 (WW191AA) completely
abrogated binding (Table 4). This is consistent with the intimate
interactions these residues make with the hydrophobic
pocket on the BTD and with previous work that demonstrated
the importance of the 4W4P motif in CSL-RAM binding, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 73
Figure 3. X-Ray Structure of CSL-KyoT2-
DNA Complex
(A) Ribbon diagram of the CSL-KyoT2-DNA
structure with transparent molecular surface. CSL
is colored as described in Figure 1. KyoT2, shown
as a yellow stick representation (carbon, oxygen,
and nitrogen atoms are colored yellow, red, and
blue, respectively), binds across the BTD of CSL.
The DNA is represented as gray spheres.
(B) Zoomed-in view of the KyoT2 4W4P motif
binding in the hydrophobic pocket of the BTD.
KyoT2 electron density is shown and is derived
from a simulated annealing composite omit map
contoured at 1s.
(C) Structural overlay of KyoT2 with the RAM
domains from the human Notch1 receptor (hRAM;
pink; Choi et al., 2012) and the C. elegans Notch
receptor LIN-12 (wRAM; gray; Friedmann et al.,
2008). Corresponding ca atoms from KyoT2,
wRAM, and hRAM were aligned and docked onto
the BTD from the CSL-KyoT2-DNA complex
structure.
(D) Surface representation of the BTD
showing where previously characterized muta-
tions (colored red; F261R, V263R, A284R, and
Q333R) that affect RAM binding occur relative
to KyoT2 binding (yellow stick representation;
Yuan et al., 2012). See also Figure S2 for com-
parison of the two CSL-KyoT2-DNA complexes
contained within the asymmetric unit.
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Structure-Function of the CSL-KyoT2 Complex(Johnson et al., 2010). We then tested the binding of the KyoT2
mutant construct KD195AA, which sequence-wise corresponds
to the -GF- motif in the RAM domain of Notch (Figure 2C).
Mutation of the -GF- motif in RAM results in an 0.6 kcal/mol
loss in binding energy (Johnson et al., 2010); conversely, the
KyoT2mutant KD195AA has no effect onCSL binding (Figure 5A;
Table 4), which is consistent with our CSL-KyoT2 structure, as
residues K196 and D197 are remote to the CSL-KyoT2 interface.
The basic motif at the N terminus of RAM (Figure 2C), which
binds an electronegative patch on the BTD of CSL, contributes
a substantial 2.5 kcal/mol to the overall binding energy of
CSL-RAM complexation (Johnson et al., 2010). However,
KyoT2 does not contain an equivalent set of basic residues,
and the KyoT2 residues that correspond to the basic motif in
RAM do not interact with the electronegative patch on the
BTD. We surmised that the polar residue N182 and the basic
residue K183 upstream of our KyoT2 construct 184–210 might
be functioning in a similar manner to the basic motif in RAM.
Nonetheless, extension of our KyoT2 construct to include
residues N182/K183 had no effect on binding interactions with
CSL (Table 1).
Given that the additional motifs identified in RAM by
Johnson et al. (2010) are not present in KyoT2 and mutation of
the corresponding residues has no affect on KyoT2 binding
to CSL, we then carefully scrutinized our CSL-KyoT2 structure
to identify residues in KyoT2 that likely provide greater contribu-
tions to binding than the corresponding residues in the RAM
domain of Notch. We focused our analysis on V186 of KyoT2,74 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rightswhich makes extensive hydrophobic contacts with residues
F261 and V263 of CSL, whereas the corresponding residue
in the human Notch1 RAM structure (Q1764) contributes far
fewer interactions to the CSL-RAM interface. Because of
these structural differences, we hypothesized that the KyoT2
mutant V186A would have a much greater effect on binding
than the corresponding mutation in RAM (Q1753A). As shown
in Figure 5B and Table 4, the KyoT2 mutant V186A resulted in
at least a 5-fold reduction in binding (1 kcal/mol); however,
the RAM mutant Q1753A bound with a comparable affinity to
CSL as wild-type RAM.
Cellular Characterization of the CSL-KyoT2
Corepressor Complex
In order to validate the findings from our structural and binding
studies of CSL-KyoT2 complexes, we characterized CSL and
KyoT2 mutants in cells using transcriptional reporter assays.
For these experiments, mouse embryonic fibroblasts (MEFs)
derived from CSL null embryos were cultured and transduced
with a retrovirus that expresses either wild-type or mutant
CSL molecules (Yuan et al., 2012). Notch signaling is activated
in the MEFs by transfection of a construct that encodes the
intracellular domain of the Notch1 receptor (NICD1), which is
constitutively active in cellular assays (Jarriault et al., 1995).
Notch activity is monitored by cotransfection of the luciferase
reporter 4xCBS, which contains four iterative CSL binding
sites upstream of the luciferase coding region (Ong et al.,
2006). As shown in Figure 6A, transfection of NICD1 into MEFsreserved
Figure 4. Thermodynamic Analysis of CSL-KyoT2 Binding Interactions
Representative thermograms (raw heat signal and nonlinear least-squares fit to the integrated data) for KyoT2 binding to CSL. Forty titrations were performed per
experiment, consisting of 7 ml injections that were spaced 120 s apart.
(A) Core CSL binding to KyoT2 residues 184–210.
(B) Core CSL, prebound to a cognate DNA, binding to KyoT2 residues 184–210.
(C) BTD binding to KyoT2 residues 184–210.
(D) Core CSL binding to KyoT2 residues 182–210.
(E) Core CSL binding to KyoT2 residues 182–196.
(F) Thermodynamic profile of core CSL binding to KyoT2 residues 184–210. Thermodynamic parameters (DG, DH, and TDS) are plotted as a function of
temperature (5C, 15C, 25C, 35C). The change in heat capacity (DCP) of binding for the CSL-KyoT2 complex is 0.57 kcal/mol,K. Values are the mean of
at least three independent experiments and the errors represent the SD of multiple experiments. See also Table S1 for buried surface at CSL-KyoT2 interface
and Figure S3 for minimal KyoT2 peptide sequence that binds CSL.
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Structure-Function of the CSL-KyoT2 Complexexpressing wild-type CSL results in robust 160-fold activation
of the reporter compared with cells that were not transfected
withNICD1.However, cotransfection of a plasmid that expresses
wild-type KyoT2 severely blunts activation of the reporter,
resulting in an 16-fold reduction in reporter activity (Figure 6A).Structure 22Overall, we obtained excellent agreement between our in vitro
binding studies of CSL and KyoT2 mutants and the characteri-
zation of these mutants in cellular reporter assays. The CSL
mutants F261R and A284R, which resulted in 500-fold reduc-
tion in binding by ITC, had significantly adverse effects on the, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 75
Table 2. Calorimetric Data for KyoT2 Binding to CSL
Macromolecule KyoT2 Ligand K (M1) KD (mM) DG (kcal/mol) DH (kcal/mol) TDS (kcal/mol)
CSL 184–210 8.5 ± 2.3 3 107 0.012 10.8 ± 0.2 15.5 ± 0.7 4.7 ± 0.5
CSL + DNA 184–210 1.1 ± 0.4 3 108 0.011 10.9 ± 0.3 11.0 ± 0.6 0.03 ± 0.3
BTD 184–210 4.0 ± 0.8 3 107 0.026 10.4 ± 0.1 13.6 ± 0.4 3.3 ± 0.5
CSL 184–200 3.1 ± 0.7 3 107 0.033 10.2 ± 0.1 13.1 ± 0.6 2.9 ± 0.5
CSL 182–210 7.1 ± 1.5 3 107 0.015 10.7 ± 0.1 16.0 ± 1.0 5.2 ± 0.9
CSL 182–196 1.0 ± 0.8 3 108 0.013 10.9 ± 0.1 10.8 ± 0.6 0.1 ± 0.6
All experiments were performed at 25C. Values are the mean of at least three independent experiments and errors represent the SD of multiple
experiments. See also Table S2 for ITC data of minimal KyoT2 peptide sequence that binds CSL.
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Structure-Function of the CSL-KyoT2 Complexability of KyoT2 to repress Notch-induced activation of the re-
porter (Figures 6B and 6D). Likewise, the CSL mutants V263R
and Q333R, which only marginally affected KyoT2 binding to
CSL in vitro, had no statistically significant effect on reporter
activity compared with cells expressing wild-type CSL (Figures
6C and 6E). It should be noted that the four BTD mutants also
affect to varying degrees the ability of NICD1 to activate the
4xCBS reporter, but they do not completely abolish reporter
activity (Yuan et al., 2012). Thus, Figures 6B and 6E represent
the ability of Kyot2 to repress the residual activity of the
CSL mutants with NICD1. The KyoT2 mutant WW191AA,
which displayed no binding by ITC, had the most deleterious
effect on the ability of KyoT2 to repress NICD1 activation of
the reporter (Figure 6F). As expected, the KyoT2 mutant
KD195AA, which had no effect on CSL-KyoT2 interactions by
ITC, also had no statistically significant effect on the ability of
KyoT2 to repress transcription from the reporter (Figure 6G).
Strikingly, the KyoT2 mutant V186A, which had a 5-fold reduc-
tion of binding, had a commensurate decrease in the repressive
effect on activity from the reporter compared with wild-type
KyoT2 (Figure 6H).
DISCUSSION
Canonical Notch signaling ultimately results in changes in gene
expression, which are regulated by the transcription factor
CSL (Kopan and Ilagan, 2009). CSL binds the regulatory ele-
ments of Notch target genes and mediates transcriptional
repression and activation at these sites by forming complexes
with corepressors and coactivators, respectively (Borggrefe
and Oswald, 2009). In contrast to CSL-coactivator complexes
(e.g., the transcriptionally active CSL-NICD-MAM ternary com-
plex), much less is known about the structure and function
of CSL-corepressor complexes (Kovall and Blacklow, 2010).
Moreover, the components, structure, and assembly mecha-Table 3. Temperature Dependence of KyoT2 Binding to CSL
T (C) K (M1) KD (mM)
CSL + KyoT2 5 6.2 ± 1.4 3 107 0.017
15 8.3 ± 2.3 3 107 0.013
25 9.4 ± 1.2 3 107 0.011
35 3.5 ± 0.6 3 107 0.029
Values are the mean of at least three independent experiments and the erro
76 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rightsnism of the activator complex are, by and large, well conserved
between organisms; however, corepressor interactions with
CSL are seemingly more diverse and species specific. For
example, the mammalian corepressor KyoT2, which is not
conserved in flies or worms, tethers tandem LIM domains to
CSL via a C-terminal motif that resembles the RAM domain of
Notch (Taniguchi et al., 1998). Nonetheless, characterizing the
structure and function of both activation and repression com-
plexes that regulate transcription at target genes is not only
important for a detailed understanding of gene regulatory mech-
anisms in the Notch pathway, but it will also inform drug discov-
ery efforts that seek to modulate Notch signaling for therapeutic
purposes (Aster and Blacklow, 2012). To this end, our studies
may be particularly relevant to certain papillary renal cell carci-
nomas, in which it was shown that KyoT3 is significantly upregu-
lated, thereby suppressing Notch signaling and contributing to
tumorigenesis (Surendran et al., 2010).
Building upon our previous studies of Notch transcription
complexes, here we pursued a comprehensive structure-
function analysis of the CSL-KyoT2 corepressor complex,
in which we determined the 2.85-A˚ X-ray structure of the
CSL-KyoT2-DNA complex (Figure 3), defined the thermody-
namic parameters of CSL-KyoT2 binding interactions (Figure 4),
and validated our structural studies by characterizing CSL/
KyoT2 mutants in ITC and cellular assays (Figures 5 and 6).
Our data demonstrate that KyoT2 binds exclusively to the
BTD of CSL with low nanomolar affinity (10 nM KD; Table
2). The overall affinity of KyoT2 for CSL is unaffected by DNA
which, due to the properties of linked equilibria (Wyman and
Gill, 1990), implies that KyoT2 does not affect the affinity of
CSL for DNA. Additionally, we had excellent agreement be-
tween our ITC binding studies of CSL and KyoT2 mutants
and characterization of these mutants in cellular reporter
assays. Taken together, these data suggest that the repressive
function of KyoT2 is largely dependent on its high-affinityDG (kcal/mol) DH (kcal/mol) TDS (kcal/mol)
9.9 ± 0.1 3.9 ± 0.4 6.0 ± 0.5
10.4 ± 0.2 6.3 ± 0.3 4.2 ± 0.5
10.9 ± 0.1 14.6 ± 0.2 3.7 ± 0.2
10.6 ± 0.1 16.7 ± 0.7 6.1 ± 0.5
rs represent the SD of multiple experiments.
reserved
Figure 5. Thermodynamic Binding Analysis of KyoT2 and CSL
Mutants
Representative thermograms (raw heat signal and nonlinear least-squares
fit to the integrated data) for KyoT2 mutants KD195AA (A) and V186A (B)
binding to wild-type core CSL, and CSL mutants F261R (C), V263R (D), A284R
(E), and Q333R (F) binding to wild-type KyoT2 (184–210). Forty titrations
were performed per experiment, consisting of 7 ml injections that were spaced
120 s apart.
Structure
Structure-Function of the CSL-KyoT2 Complexinteraction with CSL, which localizes Polycomb repression
complexes at Notch target genes. Moreover, the finding that
both KyoT2 and NICD bind with high affinity to the BTD ofStructure 22CSL provides molecular insights into the putative competition
of coregulators for binding to CSL.
At first glance, KyoT2 binds CSL in much the same manner as
the RAM domain of NICD: (1) the main chain atoms of both
KyoT2 and RAM have similar binding paths across the BTD, in
which their 4W4Pmotifs display the highest degree of structural
correspondence (Figure 3C); (2) mutation of their respective
4W4P motifs abrogates binding to CSL (Table 4; Johnson
et al., 2010); (3) both KyoT2 and RAM bury similar amounts of
surface area upon complexation with CSL (Table S1); (4) both
KyoT2 and RAM are intrinsically disordered prior to binding
CSL (Figure S1; Bertagna et al., 2008); and, lastly, (5) both
KyoT2 and RAM have similar high affinity for CSL, which is
enthalpically driven and associated with a large and negative
DCp of binding (approximately 0.6 kcal/mol,K; Friedmann
et al., 2008; Johnson et al., 2010). However, closer inspection
of our CSL-KyoT2 structure and further characterization of
CSL/KyoT2 mutants reveal a number of molecular differences
that distinguish between the binding modes of KyoT2 and
RAM for CSL.
Although there is a high degree of structural correspondence
between the 4W4P motifs and neighboring residues for KyoT2
and RAM when in complex with CSL (Figure 3C), the structural
similarity between KyoT2 and RAM is noticeably reduced for
N- and C-terminal regions that are remote from the 4W4P
motif. This lack of structural correspondence is reflected in
the primary sequences of KyoT2 and RAM, which diverge in
regions outside of the 4W4P motif (Figure 2C). Importantly,
Johnson et al. (2010) showed that RAM has additional motifs
(basic, -HG-, and -GF-) outside of the 4W4P that make sig-
nificant contributions to the high-affinity CSL-RAM interaction
(Figure 2C). However, KyoT2 lacks these additional motifs and
mutation of the corresponding residues in KyoT2 has little to
no effect on complex formation (Table 4), yet KyoT2 binds CSL
as strongly as RAM does. This raises the question of how
KyoT2 achieves nanomolar affinity for CSL and what residues
outside of its 4W4P motif contribute to binding. Although a
comprehensive binding study of CSL-KyoT2 mutants is needed
to completely address this question, which is outside the scope
of our current study, a keener examination of our structure
revealed one residue in KyoT2 that plays a more important role
in binding than does the corresponding residue in RAM. Namely,
the branched hydrophobic side chain of V186, which is a gluta-
mine in Notch1 RAM (Figure 2C), contributes 1 kcal/mol
of binding energy to CSL-KyoT2 complex formation, whereas
the glutamine side chain in Notch1 RAM contributes a modest
0.2 kcal/mol to binding CSL. This is a remarkable result, given
that both KyoT2 and RAM bury similar amounts of nonpolar
surface area when in complex with CSL (Table S1) and have
similar DCp of binding values, which is correlated to the burial
of nonpolar surface area. Taken together, these data suggest
that the 4W4P motifs of KyoT2 and RAM contribute similarly
to CSL binding; however, the KyoT2 and RAM residues outside
of the 4W4P motif make significantly different energetic
contributions to complexes formed with CSL.
Our analysis of mutations in the BTD of CSL revealed
additional differences in the binding modes of KyoT2 and
RAM. Previously, we designed four disruptive mutations in the
BTD of CSL (F261R, V263R, A284R, and Q333R) that targeted, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 77
Table 4. Calorimetric Binding Data for KyoT2 and CSL Mutants
CSL Ligand K (M1) KD (mM) DG (kcal/mol) DH (kcal/mol) TDS (kcal/mol) DDG (kcal/mol)
F261R KyoT2 3.4 ± 3.9 3 105 6.3 6.8 ± 0.1 5.6 ± 0.8 1.2 ± 0.8 4.0 ± 0.2
V263R KyoT2 3.1 ± 0.7 3 107 0.019 10.5 ± 0.1 12.9 ± 0.1 2.4 ± 0.1 0.3 ± 0.2
A284R KyoT2 4.0 ± 0.8 3 105 7.2 7.0 ± 0.1 10.5 ± 0.4 3.4 ± 0.5 3.8 ± 0.2
Q333R KyoT2 2.0 ± 3.9 3 107 0.051 0.0 ± 0.1 11.7 ± 2.3 1.7 ± 2.2 0.8 ± 0.2
WT KyoT2 WW191AA NBD – – – – –
WT KyoT2 KD195AA 1.2 ± 0.7 3 108 0.012 10.9 ± 0.5 16.0 ± 1.9 5.1 ± 1.6 0.1 ± 0.5
WT KyoT2 V186A 4.0 ± 0.8 3 105 0.069 9.8 ± 0.1 13.7 ± 1.7 3.9 ± 1.8 1.0 ± 0.2
WT RAM wild-type 6.8 ± 0.8 3 107 0.015 10.7 ± 0.1 18.2 ± 1.7 7.5 ± 1.6 –
WT RAM Q1753A 2.0 ± 3.9 3 107 0.022 10.5 ± 0.2 7.50 ± 0.3 3.0 ± 0.2 0.2 ± 0.2
All experiments were performed at 25C. Values are the mean of at least three independent experiments and errors represent the SD of multiple ex-
periments. KyoT2 ligands are in the context of the construct 184–210. NBD, no binding detected.
Structure
Structure-Function of the CSL-KyoT2 Complexits interaction with the RAM domain of Notch and were based on
our structure of the CSL-NICD-MAM activation complex bound
to DNA (Yuan et al., 2012). As expected, all of these CSLmutants
had severely reduced affinity for the RAM domains of Notch1
and Notch2 (from 6- to 600-fold), with F261R having the
most detrimental effect on the binding of both Notch1 and
Notch2 RAM (Table S2; Yuan et al., 2012). However, a subset
of these CSL mutants behaved very differently in binding exper-
iments with KyoT2. Whereas the mutants F261R and A284R
had drastically reduced affinity for KyoT2 (>500-fold), the BTD
mutant V263R had no significant effect on binding (1.6-fold)
and the Q333R mutant only modestly affected binding to CSL
(4.3-fold; Table S2). Moreover, these results were consistent
with our cellular studies of KyoT2 with these CSL mutants. This
is in stark contrast to the effect V263R and Q333R have on
RAM binding (Table S2). Consistent with the observed changes
in affinity, the mutants F261R and A284R map to regions on
the BTD where there is a high degree of structural similarity
between KyoT2 and RAM, whereas V263R and Q333R map to
regions where the binding paths of KyoT2 and RAM diverge
(Figures 3C and 3D). Interestingly, our binding analysis of CSL
mutants largely mirrors previous studies, which identified muta-
tions in the BTD of CSL that discriminated between RAM and
EBNA2 binding (Fuchs et al., 2001). Through random mutagen-
esis and yeast two-hybrid approaches, Fuchs et al. (2001) iden-
tified mutations at residues F261, K275, A284, and Q333 in the
BTD of CSL that retained binding of either RAM or EBNA2, but
not both; three of these mutants were later confirmed in ITC
binding studies by Johnson et al. (2010). Taken together, the
data presented here, as well as in previous studies, strongly
suggest that although the structures of KyoT2 or RAM bound
to CSL are generally similar, the peripheral regions of the
KyoT2/RAM binding sites on the BTD display different selectivity
toward different ligands, which leads to differential binding
modes by KyoT2 and RAM, as well as by EBNA2, for CSL.
Although the in vivo significance of these findings remains
to be determined, it should be mentioned that a number of
CSL-interacting coregulators have been identified, in both
metazoans and viruses, that have motifs loosely resembling
the 4W4P motif and are thought to interact with the BTD of
CSL: for example, the Epstein-Barr virus corepressor EBNA3C
(Calderwood et al., 2011), the Kaposi’s sarcoma-associated78 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rightsherpesvirus viral interferon regulatory factor 4 (Heinzelmann
et al., 2010), and the mammalian corepressor RITA (Wacker
et al., 2011). Certainly it will be of interest in future studies
to characterize the structure and binding of these coregulators
in complex with CSL and to compare these findings with our
current and previous studies of CSL-KyoT2 and CSL-RAM
complexes.
EXPERIMENTAL PROCEDURES
Cloning, Protein Expression, and Purification
The core domain of mouse CSL (53–474) or the BTD of CSL (203–393) was
cloned into the pGEX6P1 vector, expressed, and purified as previously
described (Friedmann and Kovall, 2010). Briefly, glutathione S-transferase-
CSL fusion constructs were overexpressed in bacteria and further isolated
via glutathione-Sepharose affinity chromatography. The fusion protein was
then cleaved with PreScission Protease, and the resulting CSL construct
was purified to homogeneity using ion exchange and size exclusion chroma-
tography. Mutants of CSL were made using site-directed mutagenesis and
purified in the same manner as wild-type CSL.
Residues 184–210 and 184–200 of KyoT2 were cloned into the pSMT3 vec-
tor, which has the suppressor of Mif2 temperature-sensitive mutant 3 (SMT3)
gene inserted into the pET28b(+) backbone (Mossessova and Lima, 2000).
Expression from this plasmid results in a His-SMT3-KyoT2 fusion protein.
KyoT2 constructs were transformed into bacteria BL21(DE3) Tuner cells and
were grown and overexpressed using autoinduction medium and methods
(Studier, 2005). Bacteria were harvested using centrifugation and lysed using
a high-pressure homogenizer. Bacterial lysates were cleared by centrifugation
and incubated with Ni-NTA resin (QIAGEN). The bead slurry was poured into a
column, washed with buffer, and eluted with buffer containing imidazole,
following the manufacturer’s protocol. Ulp-1 protease was used to cleave the
His-SMT3-KyoT2 fusion protein, which cleaves after the SMT3moiety, leaving
an additional serine residue attached to the N terminus of KyoT2. A His hi-trap
column (GE Healthcare Life Sciences) was used to separate His-SMT3 from
KyoT2, and KyoT2 was purified to homogeneity using size exclusion chroma-
tography. KyoT2 mutants and variants were made using site-directed muta-
genesis and purified in the same manner as KyoT2 wild-type proteins.
A peptide corresponding to KyoT2 residues 182–196 was chemically synthe-
sized and purified using reverse-phase high-pressure liquid chromatography.
Peptides corresponding to KyoT2 residues 184–197, 186–197, 187–196,
188–195, 189–194, and 190–193 were chemically synthesized and ordered
95% pure from Peptide2.0. All KyoT2 constructs and mutants were verified
through DNA sequencing and MALDI-TOF mass spectrometry analysis.
Crystallization and Data Collection
CSL-KyoT2-DNA complexes, which consist of residues 53–474 of the
CSL surface entropy reduction mutation R115T, KyoT2 (184–210), and anreserved
Figure 6. Analysis of KyoT2 and CSL Mutants in Cellular Reporter Assays
(A) Effects KyoT2 andCSLmutations have on luciferase activity induced byNICD1 from the 4xCBS reporter inMEFs. Addition of NICD1 results in robust activation
from the reporter (160-fold); however, increasing concentrations of wild-type KyoT2 results in potent repression from the reporter.
(B–H) Data are normalized to cells without NICD1 and shown as fold activation. Increasing concentrations of wild-type KyoT2 are titrated into MEFs expressing
CSLmutants F261R (B), V263R (C), A284R (D), or Q333R (E). Increasing concentrations of KyoT2mutants [WW191AA (F), KD195AA (G), or V186AA (H)] are titrated
into MEFs expressing wild-type CSL. For (B–H), data are normalized to cells with NICD1, but without KyoT2, and shown as relative activity; mutant and wild-type
data are shown in dark and light gray bars, respectively. The data shown are derived from three independent experiments performed in duplicate and represent
the means ± SE. Statistical significance was assessed using paired Student’s t tests with *p% 0.05, **p% 0.01; ns, not significant.
Structure
Structure-Function of the CSL-KyoT2 Complex
Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 79
Structure
Structure-Function of the CSL-KyoT2 Complexoligomeric DNA duplex containing a single CSL binding site with single-
stranded TT/AA overhangs (TTACTGTGGGAAAGA, AATCTTTCCCACAGT)
were formed bymixing the components in a 1:1.1:1.1 ratio. Initial crystallization
conditions were identified using the Hampton Research Index screen and an
Art Robbins Phenix Crystallization Robot. Crystals were further optimized
using microbatch under oil methods, and the final optimized conditions were
0.1 M HEPES, pH 7.2, 21% polyethylene glycol 3350 (PEG 3350), 0.2 M
ammonium acetate. Crystals were cryoprotected with ethylene glycol and
flash frozen in liquid nitrogen. Data were collected at the Advanced Photon
Source (APS), beamline Life Sciences Collaborative Access Team (LS-CAT).
Crystals nominally diffracted to 2.85 A˚ and belong to the space group P21
with the following unit cell dimensions: a = 62.16 A˚, b = 97.29 A˚, and
c = 144.10 A˚ (see Table 1). All data were integrated and scaled using
HKL2000 (Otwinowski and Minor, 1997).
Structure Determination, Model Building, and Refinement
Phaser (Storoni et al., 2004), within the Phenix GUI (Adams et al., 2010), was
used to solve the CSL-KyoT2-DNA structure, using our previous mouse
CSL-DNA structures (3BRG and 3IAG; Friedmann and Kovall, 2010; Fried-
mann et al., 2008). The Phaser solution revealed that there are two complexes
within the asymmetric unit. Coot (Emsley and Cowtan, 2004) was used to
manually build the KyoT2 residues into density and for the rebuilding of the
model following refinement. Refinement of the CSL-KyoT2 structure was
initially performed using Phenix, and Buster (Smart et al., 2012) was used for
later rounds of refinement. Both noncrystallographic symmetry and transla-
tion/libration/screw were used during refinement. The structure was validated
with Molprobity (Chen et al., 2010) and deposited into the Protein Data Bank
(PDB) under the accession code 4J2X. Pymol was used to create all structure
figures as well as to perform all structural comparisons (Schro¨dinger, 2010).
This PISA server was used for buried surface area calculations (Krissinel and
Henrick, 2007).
Isothermal Titration Calorimetry
ITC experiments were carried out using a MicroCal VP-ITC microcalorimeter.
All experiments were performed at 25C in a buffer composed of 50 mM
sodium phosphate, pH 6.5, and 150 mM NaCl. CSL and KyoT2 proteins
were degassed and buffer-matched using dialysis and size exclusion chro-
matography, respectively. A typical experiment was carried out with 10 mM
CSL in the cell and 100 mM KyoT2 in the syringe. The data were analyzed
using ORIGIN software and fit to a one-site binding model.
Cellular Assays
As described previously, MEFs derived from CSL knockout embryos (OT11)
were transduced with retroviruses that express either wild-type or mutant
CSL proteins (Yuan et al., 2012). Briefly, retrovirally transduced MEFs
were grown to 80% confluence in six-well plates and transiently transfected
with an NICD1 construct (murine Notch1, residues 1744–2531, which is
constitutively active), the luciferase reporter 4xCBS that contains four
iterative CSL-binding sites, and the construct phRL, which expresses Renilla
luciferase, to normalize for transfection efficiency. In addition, full-length
wild-type or mutant (V186A, KD195AA, WW191AA) KyoT2 was cotransfected
in increasing concentrations to measure the repressive effects of KyoT2
upon Notch-mediated activation of the 4xCBS reporter. The SatisFection
reagent (Agilent Technologies) was used for all transfections, following the
manufacturer’s protocol. The amount of transfected DNA was normalized
using pBluescript (Stratagene). Cells were harvested 48 hr posttransfection
and luciferase activity was measured using the Dual Luciferase Kit (Promega).
Firefly luciferase activity from the 4xCBS reporter was first normalized to
Renilla luciferase activity and reported as either fold activation or relative
activity. Average values, errors, and SD were determined from three inde-
pendent experiments performed in duplicate.
Circular Dichroism
CD measurements were taken in triplicate using an Aviv Circular Dichroism
Spectrometer model 215 at 25C in a 0.02-cm cuvette. Wavelength scans
were performed between 190 and 290 using 1.0-nm increments. KyoT2
(184–210) was characterized in a buffer containing 50 mM sodium phosphate,
pH 6.5, and 75 mM NaCl at a concentration of 0.35 mg/ml (120 mM). CD data80 Structure 22, 70–81, January 7, 2014 ª2014 Elsevier Ltd All rightswere analyzed on DiChroweb using the CDSSTR analysis program with
reference set 7 (Whitmore and Wallace, 2004).
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